Immunology of delirium: new opportunities for treatment and research
- 1 October 2001
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 179 (4) , 288-289
- https://doi.org/10.1192/bjp.179.4.288
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Decreased Plasma Insulin-Like Growth Factor-I Level in Familial Alzheimer’s Disease Patients Carrying the Swedish APP 670/671 MutationDementia and Geriatric Cognitive Disorders, 1999
- Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin‐releasing hormone and GH‐releasing hormoneClinical Endocrinology, 1999
- Asphyxial brain injury—the role of the IGF systemMolecular and Cellular Endocrinology, 1998
- Insulin-like Growth Factor-1 (IGF-1) Improves both Neurological Motor and Cognitive Outcome Following Experimental Brain InjuryExperimental Neurology, 1997
- DiscussionTrends in Neurosciences, 1997
- Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a Phase II safety and efficacy trialJournal of Neurosurgery, 1997
- Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in StrokeStroke, 1995
- A long-term follow-up study of cerebrospinal fluid somatostatin in deliriumActa Psychiatrica Scandinavica, 1994
- Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's diseaseBrain Research, 1992
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989